Cloud-Based Drug Discovery Platform Market: Global Industry Analysis and Forecast 2016 - 2026
Cloud-based computing is a way to help pharmaceutical researchers across the globe to form effective drug discovery teams without large investments in technology, computing resources or fixed running costs.
Cloud-based computing is a way to help pharmaceutical researchers across the globe to form effective drug discovery teams without large investments in technology, computing resources or fixed running costs.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Persistence <strong>Market</strong> Research<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong><br />
<strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong><br />
<strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Persistence <strong>Market</strong> Research 1
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report on “<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong><br />
<strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong>”.<br />
The pharmaceutical industry is rapidly restructuring <strong>and</strong> going through tidal wave of changes in<br />
its drug discovery process. The businesses are opting for a model which is fully integrated <strong>and</strong><br />
networked R&D. Increasing number of stages in the drug discovery process are being<br />
conducted through external collaborators <strong>and</strong> contract research organizations (CROs). Such<br />
rapid restructuring represents great challenges in implementation of the systems required for a<br />
collaborative research, <strong>and</strong> to further ensure that these networks operate efficiently, augment<br />
innovation, <strong>and</strong> at the same time lower the cost of drug discovery. <strong>Cloud</strong>-based drug discovery<br />
platforms are exclusively designed to help drug discovery companies to overcome the major<br />
hurdle of data, which has been created due to the fundamental restructuring of their research<br />
businesses.<br />
Request TOC (table of content), Figures <strong>and</strong> Tables of the Report:<br />
http://www.persistencemarketresearch.com/toc/11020<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: Drivers & Restraints<br />
<strong>Cloud</strong>-based computing is a way to help pharmaceutical researchers across the globe to form<br />
effective drug discovery teams without large investments in technology, computing resources or<br />
fixed running costs. The cloud-based platforms substantially reduces the overall time required in<br />
the drug discovery process. Toxicity prediction of a newly discovered drug is one of the<br />
restraints in the drug discovery process. Despite decades of unmatched funding by institutions,<br />
scientists are still facing problems in predicting the potent toxic side effects of a particular drug.<br />
The global cloud-based drug discovery platform market could be adversely affected by the huge<br />
investment requirements in the technical infrastructure for the identification of compounds that<br />
will cause a desired, optimum biological effect.<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: Segmentation<br />
The global cloud-based drug discovery platform market is classified on the basis of region.<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: Overview<br />
Persistence <strong>Market</strong> Research 2
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Scientists worldwide are attempting to discover newer drugs for treatment of more <strong>and</strong> more<br />
diseases than ever before. Currently, the drug discovery procedure involves identification of<br />
likely c<strong>and</strong>idates, screening them to test biologically active <strong>and</strong> effective compounds. <strong>Discovery</strong><br />
of a promising drug c<strong>and</strong>idate quickly is a technical challenge for scientific researchers. But<br />
companies such as Microsoft Research have discovered a technological solution to this issue, a<br />
cloud-based drug discovery platform Molplex <strong>Cloud</strong>s Against Disease. The company has used<br />
their computational platform deployed in the cloud to select 100 compounds from a trillion<br />
possible chemical structures which had the potential to be powerful drug agents against<br />
antibiotic-resistant bacteria. From these findings, the lab results provided 10 c<strong>and</strong>idate<br />
structures with effective biological activity, further unveiling opportunities to treat a new type of<br />
antibiotic-resistant bacteria.<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: Region wise Overview<br />
Geographically, global cloud-based drug discovery platform market is classified into regions viz.<br />
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan<br />
(APEJ), Japan, Middle East <strong>and</strong> Africa (MEA). <strong>Cloud</strong>-based drug discovery platform provides<br />
researchers an access to a state-of-the-art corporate data centre, wherein huge amount of data<br />
can be analysed efficiently. <strong>Global</strong> cloud-based drug discovery platform market is in its growth<br />
phase <strong>and</strong> its adoption is gaining momentum. <strong>Cloud</strong>-based drug discovery platform providers<br />
are accumulated in the U.S., U.K., Canada <strong>and</strong> few other European countries. As a result, North<br />
America <strong>and</strong> Europe regions are expected to account for more than half the share in the cloudbased<br />
drug discovery platform market.<br />
To Buy This Report : http://www.persistencemarketresearch.com/checkout/11020<br />
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: Key Players<br />
The key players in global cloud-based drug discovery platform market are Microsoft, BIOVIA,<br />
AstraZeneca, Accenture, Collaborative <strong>Drug</strong> <strong>Discovery</strong>, Inc., BioXcel Corporation, twoXAR,<br />
Incorporated, Seven Bridges, IBM to name a few. A major trend witnessed in the global cloudbased<br />
drug discovery platform is collaborations, particularly of drug discovery companies,<br />
universities, software <strong>and</strong> research companies, cloud management companies <strong>and</strong> so on. Such<br />
collaborative partnerships are enabling drug discovery companies to develop clouds against<br />
diseases while offering a high-quality drug discovery service based on a new molecular<br />
discovery platform that associates its power from cloud computing.<br />
Persistence <strong>Market</strong> Research 3
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
The research report presents a comprehensive assessment of the market <strong>and</strong> contains<br />
thoughtful insights, facts, historical data, <strong>and</strong> statistically supported <strong>and</strong> industry-validated<br />
market data. It also contains projections using a suitable set of assumptions <strong>and</strong> methodologies.<br />
The research report provides analysis <strong>and</strong> information according to categories such as market<br />
segments, geographies, accessories <strong>and</strong> applications.<br />
The report covers exhaustive analysis on:<br />
• <strong>Market</strong> Segments<br />
• <strong>Market</strong> Dynamics<br />
• <strong>Market</strong> Size<br />
• Supply & Dem<strong>and</strong><br />
• Current Trends/Issues/Challenges<br />
• Competition & Companies involved<br />
• Technology<br />
• Value Chain<br />
Regional analysis includes<br />
• North America (U.S., Canada)<br />
• Latin America (Brazil, Rest Of Latin America)<br />
• Western Europe (Germany, Italy, France, U.K, Spain, Rest Of Western Europe)<br />
• Eastern Europe (Russia, Rest Of Eastern Europe)<br />
• Asia Pacific (China, India, ASEAN, Australia & New Zeal<strong>and</strong>)<br />
• Japan<br />
• Middle East <strong>and</strong> Africa (GCC countries, S. Africa <strong>and</strong> Rest Of MEA)<br />
The report is a compilation of first-h<strong>and</strong> information, qualitative <strong>and</strong> quantitative assessment by<br />
industry analysts, inputs from industry experts <strong>and</strong> industry participants across the value chain.<br />
The report provides in-depth analysis of parent market trends, macro-economic indicators <strong>and</strong><br />
governing factors along with market attractiveness as per segments. The report also maps the<br />
qualitative impact of various market factors on market segments <strong>and</strong> geographies.<br />
Persistence <strong>Market</strong> Research 4
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Report Highlights:<br />
• Detailed overview of parent market<br />
• Changing market dynamics in the industry<br />
• In-depth market segmentation<br />
• Historical, current <strong>and</strong> projected market size in terms of volume <strong>and</strong> value<br />
• Recent industry trends <strong>and</strong> developments<br />
• Competitive l<strong>and</strong>scape<br />
• Strategies of key players <strong>and</strong> products offered<br />
• Potential <strong>and</strong> niche segments, geographical regions exhibiting promising growth<br />
• A neutral perspective on market performance<br />
• Must-have information for market players to sustain <strong>and</strong> enhance their market<br />
footprint.<br />
PMR for Journalist: http://www.persistencemarketresearch.com/page/journalist-resources.asp<br />
About Us<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics <strong>and</strong> market research methodology to help businesses<br />
achieve optimal performance.<br />
To support companies in overcoming complex business challenges, we follow a multidisciplinary<br />
approach. At PMR, we unite various data streams from multi-dimensional sources.<br />
By deploying real-time data collection, big data, <strong>and</strong> customer experience analytics, we deliver<br />
business intelligence for organizations of all sizes.<br />
Persistence <strong>Market</strong> Research 5
<strong>Cloud</strong>-<strong>Based</strong> <strong>Drug</strong> <strong>Discovery</strong> <strong>Platform</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>2016</strong> - <strong>2026</strong><br />
Contact<br />
Persistence <strong>Market</strong> Research<br />
305 Broadway<br />
7th Floor, New York City,<br />
NY 10007, United States,<br />
USA - Canada Toll Free: 800-961-0353<br />
Email: sales@persistencemarketresearch.com<br />
media@persistencemarketresearch.com<br />
Web: http://www.persistencemarketresearch.com<br />
Persistence <strong>Market</strong> Research 6
Change language